ERIC 2018 | Novel ventoclax combinations for CLL

Eva Kimby

The future of chronic lymphocytic leukemia (CLL) treatment is bright and looking towards novel combinations. Here, Eva Kimby, MD, PhD, of the Karolinska University Hospital, Solna, Sweden, gives us her thoughts on promising novel therapies, including venetoclax combinations. This interview took place at the European Research Initiative on CLL (ERIC) International Meeting 2018, held in Barcelona, Spain.

Share this video